ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.1 | 0.1 |
| Total income | 0.1 | 0.1 | 0.1 |
| Profit before exceptional items & tax | -0.0 | 0.0 | 0.0 |
| Profit before tax | -0.0 | 0.0 | 0.0 |
| Net profit | -0.0 | 0.0 | 0.0 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +0.00% |
|---|
BSE results filing, NSE: OMKARPH. Figures extracted from the filing.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹6.09
- Market cap
- ₹6.14 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 72.1×Sector 35.5×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Board Meeting Date
Omkar Pharmachem intimates a board meeting on 14 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 16 November 2026.
Omkar Pharmachem Other Announcement
Omkar Pharmachem Ltd filed its quarterly shareholding pattern and provided an explanation regarding missing PAN details for certain public shareholders.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Limited concluded its 31st Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and approval of material related party transactions.
Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Board Meeting Outcome
Omkar Pharmachem Ltd has announced the outcome of its board meeting, including the schedule for its 31st Annual General Meeting and related party transactions approval.